<DOC>
	<DOCNO>NCT01953237</DOCNO>
	<brief_summary>We propose develop pilot test effect mobile smartphone intervention , MedActive , improve antipsychotic adherence among individual schizophrenia .</brief_summary>
	<brief_title>MedActive : A Smartphone Intervention Improve Adherence Antipsychotic Medications</brief_title>
	<detailed_description>Up 60 % individual schizophrenia take antipsychotic medication prescribe , lead symptom relapse , decrease functioning , hospitalization , increase healthcare cost . Recent study patient- pharmacy-based intervention utilize behavioral tailoring , environmental support , medication monitor show promise improve antipsychotic adherence . However , continue need effective adherence-enhancing intervention ( AEIs ) less resource intensive widely accessible broad range individual need assistance medication management . Over last decade , technological advance internet cellular communication , include emergence mobile 'smartphones ' , revolutionized way society communicates . Whereas variety mobile phone-based application show effective improve health outcome medication adherence number medical condition , application develop individual schizophrenia . Therefore , response NIMH PAR-09-173 , propose develop pilot test effect mobile smartphone intervention , MedActive , improve antipsychotic adherence among population . We use Information-Motivation-Behavioral ( IMB ) Skills Model adherence theoretical framework inform conceptualization MedActive . The IMB Skills Model posit individual well-informed motivate adhere enact adherence-related behavioral skill lead adherence behavior favorable health outcome . MedActive provide personalized reminder patient take antipsychotic medication prescribe query intention take medication , occurrence side effect , presence positive psychotic symptom . Summaries ecological momentary assessment adherence , symptom , side effect make available individual phone psychiatrist secure , online clinician interface . Using iterative user-centered design approach , specific aim proposal ( 1 ) collaborate individual schizophrenia , psychiatrist expert advisory group develop initial version MedActive ; ( 2 ) conduct laboratory usability test short-term field trial 10 individual schizophrenia psychiatrist determine preliminary acceptability feasibility MedActive clinical practice ; ( 3 ) conduct randomize pilot trial MedActive compare provide smartphone alone 40 individual schizophrenia psychiatrist evaluate effect antipsychotic adherence . We also explore whether psychiatric symptom neuropsychological impairment moderate effect MedActive adherence . If show effective , MedActive introduce paradigm shift medication self-management individual schizophrenia treatment monitoring clinician .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Decisional capacity provide inform consent Chart diagnosis schizophrenia schizoaffective disorder Currently prescribe least one oral antipsychotic medication Self administers least one oral antipsychotic medication 1864 year age English Speaking Be able read English Has visual , hearing , voice , motor impairment would prevent completion study procedure use mobile phone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>antipsychotic medication adherence</keyword>
	<keyword>mobile phone</keyword>
</DOC>